News

The story continued beyond the concert with Visual Aid for Band Aid, Fashion Aid, Sport Aid, and then Live 8—the global series of benefit concerts featuring more than 1,000 musicians that ...
The DOB reported the state will spend nearly $2 billion on the migrant crisis by next April – adding $358 million in spending on top of the crisis’ current $1.5 billion tab. That includes ...
Novartis' CAR-T Kymriah has become the first therapy in the category to be approved for the treatment of relapsed/refractory follicular lymphoma, ahead of Gilead Sciences' rival Yescarta.
All the latest PC video gaming reviews from Rock Paper Shotgun.